The new Medicare drug price negotiation list isn't about saving seniors money; it’s a calculated political strike against Big Pharma.
The political assault on NCAR isn't about data; it’s a calculated power play against federal science funding independence. Analyze the hidden agenda.
The bipartisan funding of US science agencies wasn't a victory for research; it was a brutal political checkmate exposing deep institutional divides.
J&J's MFN deal signals a major shift in US pharma manufacturing, but is this national security win actually a massive economic trap?
Governor Newsom's explosive statement exposes a dangerous, unspoken battle over childhood immunization schedules and public health.
Life science executives learned a painful lesson from political whiplash. It’s not about ideology; it's about predictable regulatory capture.
Investigating the true cost of proposed 2025 federal research budget cuts. Who profits when American science stalls?
The withdrawal of Trump-era healthcare funding in Buffalo reveals a structural failure far beyond local politics. Explore the real impact on vulnerable patients.
Unpacking the destabilizing cuts to US science funding. The hidden winners and losers in the war on research.
The massive Trump-era visa fee increase isn't just paperwork; it's a silent killer for **rural health providers** struggling with physician shortages.